Skip to main content
Fig. 5 | BMC Medicine

Fig. 5

From: Construction of a risk stratification model integrating ctDNA to predict response and survival in neoadjuvant-treated breast cancer

Fig. 5

The association between the dynamic changes of ctDNA and DFS or response in the course of NAC. A Patients with complete ctDNA data for four time points (n = 50) were grouped according to the different patterns of ctDNA clearance or non-clearance. B Sankey plot showing the dynamic changes of patients with complete ctDNA data and DFS data (n = 45). C Sankey plot showing ctDNA dynamics in ctDNA-positive patients at T0. D DFS in ctDNA-cleared patients and non-cleared patients during NAC. E Kaplan–Meier analysis of DFS stratified based on ctDNA status after NAC (T3) and response to treatment, RCB means no-pCR

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us